Join Now

Yearly Archives: 2022

HEALTHCARE POLICY FIGURES PROMINENTLY IN $1.7 TRILLION OMNIBUS GOVERNMENT FUNDING BILL

Congress is expected to vote this week on a massive omnibus government funding bill that would run through the end of the 2023 fiscal year. The legislative text was released on Tuesday. The $1.7 trillion, 4,155-page bill includes a number of significant healthcare provisions. Of particular interest to the life sciences industry are provisions included […]

Posted in Policy News | Leave a comment

IONIQ is “Clinical Diagnostics Solution of the Year 2022”

IONIQ is “Clinical Diagnostics Solution of the Year 2022”

Posted in BioUtah News | Tagged | Leave a comment

IONIQ Science 2022 year-end update

For IONIQ Sciences, 2022 was another big year. As we respond to the FDA’s substantive review of our De Novo application for the ‘breakthrough‘ IONIQ ProLung Test, powerful macroeconomic factors are highlighting the importance of early cancer detection. Despite uncertain conditions in the financial market, we have a compelling message for potential institutional and strategic investors at […]

Posted in BioUtah News | Tagged | Leave a comment

2022 BIO Report Ranks Utah in the Top Eight States for Bioscience Specialization

The 2022 TEConomy/BIO report, The US Bioscience Industry: Fostering Innovation and Driving America’s Economy Forward, examines the bioscience industry’s impact on the national economy and provides state specific data, with Utah and its major metropolitan areas ranking high in specialized employment concentration in three major subsectors – medical device manufacturing, pharmaceuticals, research, testing and medical laboratories […]

Posted in BioUtah News | Leave a comment

Participate in Life Sciences Day on the Hill

The annual Life Sciences Day on the Hill provides our industry with the opportunity to get face time with legislators and other government officials during the 2023 legislative session. Slated for Friday, January 27, 2023 from 11:00 AM to 2:00 PM, the event permits BioUtah members to demonstrate their important breakthroughs, devices and innovations. It […]

Posted in BioUtah News | Leave a comment

Stryker launches state-of-the-art Neurovascular R&D lab with advanced technology to accelerate stroke care innovation

Stryker, one of the world’s leading medical technology companies, recently opened its Neurovascular (NV) lab, a state-of-the-art lab designed to accelerate stroke-related innovation in Asia Pacific. Located within the Stryker Global Technology Center (SGTC) at International Park, Gurgaon, India, the Keystone Suite will enable collaboration between customers, product development engineers, cross-functional teams, and other key […]

Posted in BioUtah News | Leave a comment

Merrimack provides Ipsen report that Onivyde® regimen demonstrated statistically significant improvement in overall survival in previously untreated metastatic pancreatic ductal adenocarcinoma

Cambridge, MA, November 9, 2022 /Business Wire/ – Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) [(“Merrimack” or the “Company”)] announced that Ipsen, SA (“Ipsen”) issued a press release today reporting its primary analysis of the results of its Phase III NAPOLI 3 trial of Onivyde® (irinotecan liposome injection) plus 5 fluorouracil/leucovorin and oxaliplatin (NALIRIFOX regimen) as a […]

Posted in BioUtah News | Leave a comment

Utah Life Sciences Companies participate in Utah Trade Delegation to Medica 2022

Exhibiting their innovative products and services to over 80,000 visitors, 11 life science companies represented Utah at the MEDICA trade show in Düsseldorf, Germany. Looking across the global landscape of innovative healthcare products, Charlotte Serage, WTC Utah’s manager of trade shows and trade missions, said, “It’s clear that Utah is a major player.” Shoutout to EVŌQbio, Matia Mobility, NanoSpot.ai, SINTX […]

Posted in BioUtah News | Leave a comment

Halia Therapeutics Presents at 4th Inflammasome Therapeutics Summit

SALT LAKE CITY–(BUSINESS WIRE)–Halia Therapeutics, a clinical stage biopharmaceutical company advancing innovative medicines to treat diseases driven by chronic inflammation, was invited to present today at the 4th Inflammasome Therapeutics Summit. Dr. David J. Bearss, CEO of Halia Therapeutics, will chair a panel entitled, “Advances in Proof-of-Concept Trials & Moving Towards the Clinic,” and also […]

Posted in BioUtah News | Leave a comment

Renalytix Reports Financial Results for First Quarter of Fiscal Year 2023

LONDON and SALT LAKE CITY, Nov. 30, 2022 (GLOBE NEWSWIRE) — Renalytix plc (NASDAQ: RNLX) (LSE: RENX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and advance value-based care, today reported financial results for the fiscal first quarter ended September 30, 2022. Recent […]

Posted in BioUtah News | Leave a comment

Ortho Development Launches Enabling Technology for Total Knee

by Julie A. Vetalice Ortho Development BKS Total PSI has been released for commercial distribution in the United States in collaboration with Materialise, a provider of additive manufacturing software and 3D printing solutions. BKS Total PSI is compatible with Ortho Development’s BKS and BKS TriMax total knee replacement systems. BKS Total PSI, powered by Materialise, […]

Posted in BioUtah News | Leave a comment

Sumitomo Pharma Oncology to Present Preliminary Clinical Data Evaluating Investigational Agent TP-3654 at the 64th ASH Annual Meeting & Exposition

Sumitomo Pharma Oncology to Present Preliminary Clinical Data Evaluating Investigational Agent TP-3654

Posted in BioUtah News | Tagged | Leave a comment